(1)連結損益計算書

(単位:百万円)

 

 

前年度

(自  2023年4月1日

  至  2024年3月31日)

当年度

(自  2024年4月1日

  至  2025年3月31日)

売上収益

 

4,263,762

4,581,551

売上原価

 

1,426,678

1,580,217

販売費及び一般管理費

 

1,053,819

1,104,766

研究開発費

 

729,924

730,227

製品に係る無形資産償却費及び減損損失

 

652,117

643,233

その他の営業収益

 

19,379

26,212

その他の営業費用

 

206,527

206,733

営業利益

 

214,075

342,586

 

 

 

 

金融収益

 

52,093

46,549

金融費用

 

219,850

210,065

持分法による投資損益

 

6,473

3,986

税引前当期利益

 

52,791

175,084

法人所得税費用

 

91,406

66,941

当期利益

 

144,197

108,143

 

 

 

 

 

 

 

 

当期利益の帰属

 

 

 

親会社の所有者持分

 

144,067

107,928

非支配持分

 

130

215

合計

 

144,197

108,143

 

 

 

 

 

 

 

 

1株当たり当期利益(円)

 

 

 

基本的1株当たり当期利益

 

92.09

68.36

希薄化後1株当たり当期利益

 

91.16

67.23

 

 

 

 

 

E00919 45020 武田薬品工業株式会社 Takeda Pharmaceutical Company Limited 通期第3号参考様式 [IFRS](連結) IFRS true cte cte 2024-04-01 2025-03-31 FY 2025-03-31 2023-04-01 2024-03-31 2024-03-31 1 false false false 45020 2025-05-08 45020 2024-04-01 2025-03-31 45020 2024-04-01 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 45020 2024-04-01 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 45020 2024-04-01 2025-03-31 tse-acediffr-45020:ChangesInFairValueOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2024-04-01 2025-03-31 tse-acediffr-45020:HedgeCostIFRSMember 45020 2025-03-31 45020 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 45020 2025-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2025-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45020 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 45020 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 45020 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 45020 2025-03-31 tse-acediffr-45020:ChangesInFairValueOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2025-03-31 tse-acediffr-45020:HedgeCostIFRSMember 45020 2023-04-01 2024-03-31 45020 2023-04-01 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 45020 2023-04-01 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2023-04-01 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2023-04-01 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2023-04-01 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45020 2023-04-01 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2023-04-01 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2023-04-01 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 45020 2023-04-01 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 45020 2023-04-01 2024-03-31 jpigp_cor:TreasurySharesIFRSMember 45020 2023-04-01 2024-03-31 tse-acediffr-45020:ChangesInFairValueOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2023-04-01 2024-03-31 tse-acediffr-45020:HedgeCostIFRSMember 45020 2024-03-31 45020 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 45020 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45020 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 45020 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 45020 2024-03-31 jpigp_cor:TreasurySharesIFRSMember 45020 2024-03-31 tse-acediffr-45020:ChangesInFairValueOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2024-03-31 tse-acediffr-45020:HedgeCostIFRSMember 45020 2023-03-31 45020 2023-03-31 jpigp_cor:CapitalSurplusIFRSMember 45020 2023-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2023-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2023-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2023-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45020 2023-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2023-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2023-03-31 jpigp_cor:RetainedEarningsIFRSMember 45020 2023-03-31 jpigp_cor:ShareCapitalIFRSMember 45020 2023-03-31 jpigp_cor:TreasurySharesIFRSMember 45020 2023-03-31 tse-acediffr-45020:ChangesInFairValueOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2023-03-31 tse-acediffr-45020:HedgeCostIFRSMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:pure